The diagnostic criteria for PCOS appear to be based on reproductive history, yet many clinicians have postmenopausal patients in their 50 s and 60 s who they believe may have PCOS.
Evanthia Diamanti-Kandarakis: This is a real problem as the only way to diagnose a postmenopausal woman with PCOS is by two criteria: elevated androgen levels and a history of chronic anovulation during her reproductive years. There has been one large study showing that the prevalence of the syndrome using these criteria, in postmenopausal women, is the same as it is in women of reproductive age, around 6-7%.
Why might a woman with a normal weight have PCOS? Is there some genetic explanation?
Evanthia Diamanti-Kandarakis: PCOS is a polygenic disorder -there is no single gene that has been allocated to the whole syndrome. Genes play a role but not the major role. Regarding normal weight women with PCOS, abdominal obesity can be present in women with PCOS regardless of BMI, so in a woman with PCOS it is important to measure not only body weight but also waist and hip circumference as these are good indicators of abdominal obesity.
If the woman has a normal weight and a normal waist measurement, then it is important to remember that insulin resistance in a woman with PCOS can be present as an intrinsic defect regardless of BMI.
So now we have a woman with PCOS, who comes along to the fertility clinic. Is there evidence that we can increase her fertility by reducing her weight? And is it safe to use drugs in that context? Donna Ryan: Studies have shown that weight loss is associated with increased ovulation and fertility. This is a population in which you would really want to stick to the Institute of Medicine guideline and try to encourage a really healthy pregnancy, with weight gain well within the guideline limit. So many of these women are insulin resistant that they are at great risk for gestational diabetes, and this is what should be on the clinician's mind.
Evanthia Diamanti-Kandarakis: I agree absolutely. We should not use any medication in pregnancy. There are published studies in which metformin has been used in pregnant women. These have shown that women can hold their pregnancies uneventfully on metformin. But these are very limited studies with small numbers of patients and we should not routinely recommend the use of drugs. The first thing we should get these women to do is to lose weight. Renato Pasquali has shown that weight loss of just 5-7% is sufficient to alter the hormonal and metabolic profile of these women.
You have described three categories of patients with psychological problems related to obesity -the schizoid obese, egodystonic obese and egosyntonic obese. PCOS clearly affects a woman's body image. Is there any evidence of a link with psychological disturbances, and which category would it come into?
Tessa van der Merwe: This is a very difficult question to answer because there is a link between obesity and depressive mood in general. Given that most polycystic women are overweight, then there will be a connection. The fact that they are very often infertile adds to that psychological burden.
It appears to be a vicious cycle: but what comes first, and how should this affect our management? Do we start off by treating the depression and the dysthymia or do we go straight for the treatment of obesity? In the experience of my clinical practice, we have first to exclude all schizoid obese patients from treatment because invariably they will run into problems. Managing these patients should be the domain of clinical psychiatrists, but we have to become far more vigilant in identifying these patients. That then leaves us with two categories of patients with a lower level of depression and anxiety that preferably should be handled by a psychologist. My approach has always been to treat these patients with sibutramine straight off if they are not already on an antidepressant. We usually see a mood improvement within 3-4 weeks. Where it is far more difficult is when we have a patient who is already on antidepressant medication. Invariably these patients present with higher depression and anxiety scores at onset. Unless there is a clear expression of suicidal thought in these patients I would bring them into the context of holistic treatment and get them to exercise and undergo dietary and behavioural modification and certainly aim to teach them certain coping skills. Then I would attempt, within about a month or two, to wean them off their antidepressant and put them onto a trial of sibutramine and to see whether in fact they feel any different on the sibutramine.
You say that we as doctors are failing to diagnose cardiovascular diseases in our female patients. At a time when more women are coming into the medical profession, is there any evidence that women are more acutely sensitive to this or is it general medical training that has led to the problem?
Serena Tonstad: I would suggest that it is the general medical training that has led to the problem. We are really not training medical students to focus on the importance of obesity. Even though they may learn about the metabolic syndrome in theory they learn very little about treating it in practice. When a physician doesn't feel comfortable with a problem they tend to overlook it and to specialise in the problems that they feel more competent in dealing with. I think there is a great potential in training young doctors in how to identify high risk people and how to treat them.
In your treatment system you talk about diet and reducing abdominal obesity. Physical activity is particularly good in reducing abdominal obesity. Is getting patients to become more physically active also a good way to deal with depression?
Serena Tonstad: Physical activity will often produce an emotional high. Patients rarely continue to do something unless they receive a tangible, immediate reward. This is what we need to focus on. We also need to focus on not getting them to do too much too quickly, as they may then get an injury that will put them back several weeks or months. Trying to make sure that they subjectively experience a reward from physical activity is very important.
If there is evidence that physical activity improves wellbeing and evidence that it improves cardiovascular risk factors, is there any evidence that physical activity can reduce the risk of Alzheimer's disease? Donna Ryan: There are a number of risk factors that are associated with Alzheimer's disease. They include socioeconomic status, education, and presence of diabetes. Given the way those risk factors and obesity track together with low physical activity and low fitness it is quite likely that there is a relationship. But it appears that obesity and metabolic risk factors are independent -they are independent of diabetes, socioeconomic status and so on.
Obesity studies are frequently dominated by women, often relatively young women. How is SCOUT different?
Walmir Coutinho: It is true that the vast majority of weight management studies selectively enrol women, often accounting for 70-80% of subjects. This is not the case in the SCOUT study. We actively tried to achieve a balance between men and women in recruiting patients to the study. This is particularly important because it means that we will be able to look at the response to treatment not only in terms of weight and waist loss but also in the cardiovascular risk reduction that this management programme can offer to both men and women.
Is there a relationship between obesity and osteoporosis, which is a major problem in elderly women? Donna Ryan: Obesity is associated with lower risk for osteoporosis. Obesity acts as a protective factor by improving bone mass and maintaining higher levels of oestrogen during the menopause. However, this is usually the only positive effect of obesity, and because of the many adverse effects of obesity and weight gain, I would recommend calcium and vitamin D supplementation, weight bearing exercise and smoking cessation over weight gain for women with or at risk from osteoporosis.
